(Circulation. 1999;100:2387.)
© 1999 American Heart Association, Inc.
Images in Cardiovascular Medicine |
From the Department of Cardiology, the Division of Nuclear Medicine, the Department of Radiology, the Division of Endocrinology, and the Division of Magnetic Resonance, Centre Hospitalier Universitaire et Centre G.F. Leclerc, Dijon, France.
Correspondence to Dr Yves Cottin, Service de cardiologie II, Centre Hospitalier Universitaire, 2 boulevard Maréchal de Lattre de Tassigny, 210134 Dijon Cedex, France.
A17-year-old
woman had paroxysmal hypertension. Very high levels of urinary
catecholamines suggested a diagnosis of pheochromocytoma
(urinary norepinephrine 27 600 nmol/24 hours, normal <485
nmol/24 hours; urinary normetanephrine 37 607 nmol/24 hours, normal
<2000 nmol/24 hours), but no adrenal tumor was found on the abdominal
CT scan. Metaiodobenzylguanidine (MIBG)
whole-body scintigraphy was performed, and no abnormal
uptake was observed. To locate the tumor,
111In-labeled pentetreotide somatostatin-receptor
scintigraphy was performed. An intense focal uptake was
seen in the thoracic area (Figure 1
). An
intravenous injection of 99mTc
microspheres was used to label the lungs. The subsequent
double-isotope tomoscintigraphy located the tumor beside
the right lung in the inferior mediastinum (Figure 1
).
|
ECG-gated MRI and transesophageal
echocardiography gave further information about the
anatomic extent of the tumor. The pheochromocytoma was located adjacent
to the right atrium (Figure 2
).
|
The patient underwent surgical removal of the tumor and had
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |